Leem report the changes set out by the Government will heighten the difficulties already being faced...
Read moreIntroduction The European landscape has seen both approvals and withdrawals of cell and gene therapi...
Read moreWe look at whether payers are willing to pay for innovative gene therapies & CAR-Ts and the impact o...
Read moreThe legislation is an updated, smaller version of The Build Back Better Act (BBBA) which the US Sena...
Read moreThe Haute Autorité de Santé (HAS), recently announced changes to the conditions in which a drug wi...
Read moreOne notable change from the last released updated bill was the removal of the solidarity levy of 2 b...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreAZ has warned its China revenues will decline mid-single-digit percentage in 2022 after years of dou...
Read moreThis updated bill contains some similar measures to those proposed in March as well as some addition...
Read moreIt is widely expected that the reform will entail the unification of the CTS and the CPR into one bo...
Read more